Summary: Roche Holding AG - S&P Global Ratings’ Credit Research

Summary: Roche Holding AG

Summary: Roche Holding AG - S&P Global Ratings’ Credit Research
Summary: Roche Holding AG
Published Nov 22, 2016
9 pages (2850 words) — Published Nov 22, 2016
Price US$ 225.00  |  Buy this Report Now

About This Report

  
Abstract:

Leading global player in fast-growing oncology indication. Excellent late-stage pipeline of drugs in development. Several key products exposed to patent expiry effects in the coming 30 months. High EBITDA margins relative to peers. Strong free cash flow generation. Conservative financial policy. The stable outlook on Switzerland-based global pharmaceutical company Roche Holding AG (Roche) reflects S&P Global Ratings' assumption that the company will maintain credit-protection metrics over the next 12-24 months of pension- and lease-adjusted ratio of funds from operations (FFO) to net debt of more than 45% and debt to EBITDA below 2x on a sustainable basis. We also take into account our view that Roche will likely maintain its excellent business positions and superior cash-generating ability, assuming strong resilience

  
Brief Excerpt:

...(Editor's Note: On July 14, 2017, we republished this article, originally published Nov. 22, 2016, to correct the management and governance descriptor in the Ratings Score Snapshot.)...

  
Report Type:

Summary

Ticker
ROG@VX
Issuer
Roche Holding AG
GICS
Pharmaceuticals (35202010)
Sector
Global Issuers
Country
Switzerland
Region
Europe, Middle East, Africa
Format:
PDF Adobe Acrobat
Buy Now

Roche Holding AG – 2017/10/31 – US$ 500.00

Summary: Roche Holding AG – 2017/10/31 – US$ 225.00

Roche Holding AG – 2018/09/28 – US$ 500.00

Summary: Roche Holding AG – 2018/09/28 – US$ 225.00

Roche Holding AG – 2019/09/18 – US$ 500.00

Roche Holding AG – 2016/11/22 – US$ 500.00

Roche Holding AG – 2014/04/28 – US$ 500.00

Summary: Roche Holding AG – 2014/04/28 – US$ 225.00

Summary: Roche Holding AG – 2013/05/27 – US$ 225.00

Summary: Roche Holding AG – 2013/04/18 – US$ 225.00

More from S&P Global Ratings’ Credit Research

S&P Global Ratings’ Credit Research—S&P Global Ratings’ credit research provides analysis on issuers and debt obligations of corporations, states and municipalities, financial institutions, insurance companies and sovereign governments. S&P Global Ratings also offers insight into the credit risk of structured finance deals, providing an independent view of credit risk associated with a growing array of debt-securitized instruments.

About the Author


Cite this Report

  
MLA:
S&P Global Ratings’ Credit Research. "Summary: Roche Holding AG" Nov 22, 2016. Alacra Store. May 23, 2025. <http://www.alacrastore.com/s-and-p-credit-research/Summary-Roche-Holding-AG-1883373>
  
APA:
S&P Global Ratings’ Credit Research. (). Summary: Roche Holding AG Nov 22, 2016. New York, NY: Alacra Store. Retrieved May 23, 2025 from <http://www.alacrastore.com/s-and-p-credit-research/Summary-Roche-Holding-AG-1883373>
  
US$ 225.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.